Bridging the gap in the recall of G6PD deficient screened babies: A policy brief
- Author:
Anthony James F. Almazan
1
,
2
;
Susielyn R. Lozano-Almazan
3
,
4
Author Information
- Publication Type:Other Types
- MeSH: Glucosephosphate Dehydrogenase Deficiency; Glucosephosphate Dehydrogenase
- From: Philippine Journal of Nursing 2022;92(2):73-79
- CountryPhilippines
- Language:English
- Abstract: Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency is an enzyme defect affecting around 400 million people worldwide. In the Philippines, cumulative data from the Newborn Screening Reference Center as of December 2020 unveils 248,285 confirmed babies out of 15,087,251 screened babies or prevalence rate of 1:60 with the national return rate of 18% only (NSRC, 2021). One strategy identified pertaining to the recall of patient is the G6PD Recall Monitoring which resulted in a 76% G6PD return rate, compared to the 31% output of the standard recall done in the Province of Ilocos Norte in CY 2020 (NSC-NL, 2022). Hence, this policy brief on G6PD Recall Monitoring serves as a supplementary policy to bridge the gaps in the recall of G6PD Deficient Patients and increase return rate of G6PD nationwide.
- Full text:Bridging the Gap.pdf
